Key points from article :
Longevity research has been evolving as a legitimate science for many years.
Edwards thinks the scale in Longevity industry will go from a 2 to an 8 in the next four to five years.
Life Biosciences now is focusing on cell reprogramming.
Longevity revolution can be valuable for Big Pharma if they will switch to being in the healthspan business.
